TRIM22 and ovarian carcinoma: Thus, the scoring model based on the gene expressions of CXCL13, IDO1, PI3, SPP1 and TRIM22 from GSE15622 dataset and constructed by lasso algorithm could better predict the sensitivity of ovarian cancer patients to chemotherapeutic drugs than which based on single gene.